SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-23-013442
Filing Date
2023-10-27
Accepted
2023-10-27 08:13:58
Documents
4
Period of Report
2023-10-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tenx_def14a.htm DEF 14A 185272
2 tenx_pre14aimg3.jpg GRAPHIC 10273
3 tenx_pre14aimg4.jpg GRAPHIC 117316
4 tenx_pre14aimg5.jpg GRAPHIC 86237
  Complete submission text file 0001654954-23-013442.txt   481425
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34600 | Film No.: 231352172
SIC: 2834 Pharmaceutical Preparations